SB17 (2017) Detail

Relative to treatment for hepatitis C under the law relative to use of cannabis for therapeutic purposes.


CHAPTER 146

SB 17 - FINAL VERSION

 

 

2017 SESSION

17-0765

01/09

 

SENATE BILL 17

 

AN ACT relative to treatment for hepatitis C under the law relative to use of cannabis for therapeutic purposes.

 

SPONSORS: Sen. Reagan, Dist 17

 

COMMITTEE: Health and Human Services

 

-----------------------------------------------------------------

 

ANALYSIS

 

This bill clarifies hepatitis C as a qualifying medical condition for the use of cannabis for therapeutic purposes.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

17-0765

01/09

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Seventeen

 

AN ACT relative to treatment for hepatitis C under the law relative to use of cannabis for therapeutic purposes.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

146:1  Use of Cannabis for Therapeutic Purposes; Definitions.  Amend RSA 126-X:1, IX(a)(1) to read as follows:

(1)  Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C [currently receiving antiviral treatment], amyotrophic lateral sclerosis, muscular dystrophy, Crohn's disease, multiple sclerosis, chronic pancreatitis, spinal cord injury or disease, traumatic brain injury, epilepsy, lupus, Parkinson's disease, Alzheimer's disease, ulcerative colitis, or one or more injuries that significantly interferes with daily activities as documented by the patient's provider; and

146:2  Effective Date.  This act shall take effect upon its passage.

 

Approved: June 16, 2017

Effective Date: June 16, 2017

Links

SB17 at GenCourtMobile

Action Dates

Date Body Type
Jan. 10, 2017 Senate Hearing
Jan. 19, 2017 Senate Floor Vote
March 21, 2017 House Hearing
March 22, 2017 House Exec Session
April 20, 2017 House Floor Vote

Bill Text Revisions

SB17 Revision: 1631 Date: June 19, 2017, 11:09 a.m.
SB17 Revision: 1632 Date: April 20, 2017, 1:29 p.m.
SB17 Revision: 1633 Date: Jan. 24, 2017, 10:47 a.m.

Docket


June 16, 2017: Signed by the Governor on 06/16/2017; Chapter 0146; Effective 06/16/2017


April 27, 2017: Enrolled (In recess 04/27/2017); SJ 16


May 4, 2017: Enrolled 05/04/2017 HJ 15 P. 47


April 20, 2017: Ought to Pass: MA VV 04/20/2017 HJ 14 P. 10


April 20, 2017: Committee Report: Ought to Pass for 04/20/2017 (Vote 13-7; RC) HC 20 P. 8


March 22, 2017: Executive Session: 03/22/2017 09:00 AM LOB 205


March 21, 2017: Public Hearing: 03/21/2017 10:45 AM LOB 205


Feb. 16, 2017: Introduced 02/16/2017 and referred to Health, Human Services and Elderly Affairs HJ 8 P. 44


Jan. 19, 2017: Ought to Pass: MA, VV; OT3rdg; 01/19/2017; SJ 4


Jan. 19, 2017: Committee Report: Ought to Pass, 01/19/2017; SC 6


Jan. 10, 2017: Hearing: 01/10/2017, Room 101, LOB, 01:45 pm; SC 5


Jan. 5, 2017: To Be Introduced 01/05/2017 and Referred to Health and Human Services; SJ 4